[Children born of ICSI]

S Epelboin1

  • 1Hôpital Cochin-Saint-Vincent-de-Paul, 82, avenue Denfert-Rochereau, 75674 Paris cedex, France.

Insights

Children born via IVF or ICSI face higher risks of prematurity and growth issues. Long-term development and health risks remain uncertain, requiring more extensive research.

Area of Science:

  • Reproductive Medicine
  • Pediatric Health
  • Genetics

Context:

  • In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) are common assisted reproductive technologies.
  • Studies on outcomes for children conceived via IVF/ICSI exhibit significant heterogeneity.
  • Existing research presents methodological challenges in assessing risks.

Purpose:

  • To review and synthesize current literature on the perinatal and long-term outcomes of children born following IVF and ICSI.
  • To identify consensus, contradictions, and knowledge gaps regarding the safety and development of these children.

Summary:

  • Perinatal data indicate increased risks of prematurity, growth retardation, and perinatal mortality for IVF/ICSI conceived children, irrespective of maternal factors or multiple pregnancies.
  • Birth defect risks associated with IVF are contradictory; ICSI risks may stem from male infertility factors or the procedure itself.
  • Long-term data on growth, cognitive/psychomotor development, cancer, and epigenetic diseases are inconclusive, though current findings are more reassuring than alarming.

Impact:

  • Highlights the need for standardized methodologies and larger, longer-term studies to definitively assess IVF/ICSI safety.
  • Informs prospective parents and clinicians about potential risks and the current state of evidence.
  • Guides future research directions in reproductive medicine and pediatric follow-up care.

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...